retatrutide peptide eli lilly Medscape | Retatrutide, Lilly's first-in-class triple hormone receptor agonist, delivered meaningful weight loss at 80 weeks in all doses in the Retatrutide 10mg & 20mg Research

Tirzepatide, a dual GIP/GLP-1 agonist, shows similarly strong results for improving insulin sensitivity and preventing progression to type 2 diabetes in high-risk individuals

Comprehensive stool analysis measuring markers relevant to digestive health

J Pharmacol Exp Ther 2013;344:141-54

In response to thyrotropin-releasing hormone (TRH) secretion by the hypothalamus, the pituitary gland secretes thyroid-stimulating hormone (TSH), which stimulates iodine trapping, thyroid hormone synthesis, and release of T 4 and T 3 by the thyroid gland

ACPs selectively bind to cancer cells, making them useful molecular probes for tumor-specific imaging